Abnormal Amyloid-β Duration, Tau, and Neurodegeneration in Cranial Images
JAMA Network Open · 2025
DOI: 10.1001/jamanetworkopen.2025.31093 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, 2025. Verfasst von Henry Gilreath Stephenson und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Public Health, University of Wisconsin-Madison, Madison. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, tau Proteins, Alzheimer Disease, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Importance It is unclear whether the duration of amyloid-β (Aβ) pathology is associated with neurodegeneration and whether this depends on the presence of tau.
Objective
To examine the association of longitudinal atrophy with Aβ positron emission tomography (PET)–positivity (Aβ+) and the estimated duration of Aβ+ (Aβ+ duration), controlling for tau-positivity. Design, Setting, and Participants Data for this longitudinal cohort study were drawn from the Wisconsin Registry for Alzheimer Prevention and the Wisconsin Alzheimer Disease Research Center Clinical Core Study. Participants who had 2 or more magnetic resonance imaging (MRI) visits, 1 Pittsburgh compound B (PiB) PET visit, and 1 MK-6240 PET visit with other covariates available were included. A replication analysis was conducted using data from the OASIS-3 dataset. All data were collected between June 1, 2009, and January 22, 2025. Follow-up times ranged from 1.0 to 13.0 years (median [IQR], 8.8 [5.9-10.6] years). Exposures Sampled iterative local approximation (SILA)-estimated PiB PET uptake at baseline MRI was used to estimate Aβ+ and its duration at baseline MRI. MK-6240 PET uptake in the entorhinal cortex was used to create tau-positive and tau-negative groups using a threshold of 1.27 standardized uptake value ratio. Main Outcomes and Measures SILA-based modeling of PiB PET data was used to obtain estimated Aβ+ duration at baseline MRI age. Linear mixed-effects models tested differences in atrophy between Aβ+ vs Aβ− individuals and with Aβ+ duration, controlling for individuals who were tau-positive (measured via MK-6240 tau PET) at their most recent PET scan within their MRI visits. Z -scored volumes in temporo-parietal regions of interest associated with AD dementia were assessed via a robust normative approach.
Results
A total of 95 Aβ+ (median [IQR] age, 66.4 [61.1-70.4] years; 59 female [62.11%]) and 275 Aβ− (median [IQR] age, 60.2 [55.7-64.6] years; 183 [66.55%] female) individuals were included. Aβ+ (partial η 2 , 0.015-0.043) and tau-positivity (partial η 2 , 0.018-0.100) were independently associated with neurodegeneration, with generally small effect sizes. Aβ+ duration was associated with atrophy in a greater number of regions of interest than Aβ+ status alone with somewhat larger effect sizes (partial η 2 , 0.013-0.056). Results were mostly similar in the OASIS-3 dataset. Conclusions and Relevance In this longitudinal cohort study, subtle neurodegeneration was observed soon after the onset of Aβ pathology. These results may be consistent with Aβ pathology as a pathological state.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine and Public Health, University of Wisconsin-Madison, Madison.
- Neuroscience Training Program, University of Wisconsin-Madison, Madison.
- Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison, Madison.
- Wisconsin Alzheimer's Institute, University of Wisconsin-Madison, Madison.
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois.
- Veterans Administration William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin.
Förderung
- NIA NIH HHS
Zitieren
APA
Stephenson, H. G., Langhough, R., Jonaitis, E., Du, L., Van Hulle, C., Chin, N. A., Okonkwo, O. C., Carlsson, C. M., Asthana, S., Christian, B. T., Johnson, S. C., Bendlin, B. B., & Betthauser, T. J. (2025). Abnormal Amyloid-β Duration, Tau, and Neurodegeneration in Cranial Images. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.31093
Vancouver
Stephenson HG, Langhough R, Jonaitis E, Du L, Van Hulle C, Chin NA, et al. Abnormal Amyloid-β Duration, Tau, and Neurodegeneration in Cranial Images. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.31093
BibTeX
@article{Stephenson2025,
author = {Stephenson, Henry Gilreath and Langhough, Rebecca and Jonaitis, Erin and Du, Lianlian and Van Hulle, Carol and Chin, Nathaniel A and Okonkwo, Ozioma C and Carlsson, Cynthia M and Asthana, Sanjay and Christian, Bradley T and Johnson, Sterling C and Bendlin, Barbara B and Betthauser, Tobey J},
title = {Abnormal Amyloid-β Duration, Tau, and Neurodegeneration in Cranial Images},
journal = {JAMA Network Open},
year = {2025},
doi = {10.1001/jamanetworkopen.2025.31093}
}
EUVIMED